UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 15, 2018

Accession Number:	0001193125-18-041617
Submission Type:	POS AM
CIK: 0001365216 Company Name: Sucampo Pharmaceuticals, Inc. File Number: 333-218641